Target intelligence / Profile preview

T cell receptor gamma variable 8 (TRGV8)

Target
TRGV8
Molecular classification
Receptor, Immunoglobulin superfamily, T cell receptor (specifically, gamma chain variable region)
01

Overview

T cell receptor gamma variable 8 (TRGV8) encodes a variable region of the gamma chain of the γδ T cell receptor complex. It participates in antigen recognition, contributing to the diversity of γδ T cells which respond to a variety of self and foreign non-peptide antigens at epithelial boundaries, including lipid antigens presented by CD1D and phosphoantigens presented by BTN3A1[1][5][6]. This receptor is a membrane protein and part of the T cell receptor complex whose engagement triggers rapid, innate-like immune responses important for pathogen clearance and tissue repair through signal transduction events in the cell[1][2][4][5]. TRGV8 is generated through V-J gene rearrangement in the gamma locus, contributing to T cell receptor diversity[1][2]. As with other T cell receptors, its role in disease is primarily through modulation of immune responses, but there are no approved drugs that directly target TRGV8, nor is it a common biomarker or pharmacological target in current clinical practice[1][4][6].

Other names
TCRGV8V1S8T-cell receptor gamma variable region V8
02

Biological functions

Immune response (adaptive and innate)Antigen recognitionSignal transductionPathogen clearanceTissue repair
03

Disease associations

Cancer (especially hematopoietic malignancies and certain leukemias, as for T cell receptors generally)InfectionOther (immune-mediated diseases)
04

Safety considerations

General concerns relate to immune modulation/activation, such as risk of unwanted immune activation, but no specific, unique concerns reported for TRGV8

Beyond the preview

Go deeper on T cell receptor gamma variable 8 (TRGV8).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on T cell receptor gamma variable 8 (TRGV8).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call